Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract IDV Awards
Help
Indefinite Delivery Contract HHSO100201700011I
Award Date
3/9/17
Last Date to Order
3/8/23
Overview
🤔 AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
2
Activity
Contract IDVs
Contract Awards
14
Transactions
4
Price Lists
Opportunity Stack
2
Federal Agency
Office of the Assistant Secretary for Preparedness and Response
Awardee
Battelle Memorial Institute
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AN13 - Health R&D Services; Health Care Services; Experimental Development
Federal Contract Vehicle
BARDA Biological Animal Model Development 2017-2022
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Clinger Cohen Act
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
BARDA Biological Animal Model Development 2017-2022
Master IDIQ
HHSO100201700011I
Indefinite Delivery Contract
14
Federal Contract Awards
Description
Update #1
BATTELLE MEMORIAL INSTITUTE (AMT) - IDIQ FOR BIOLOGICAL NONCLINICAL SERVICES
Posted 3/3/17, 12:00 AM
Mod #
Description
Reason For Modification
Federal Obligation
(Click to sort descending)
Date
(Click to sort ascending)
P00003
BATTELLE MEMORIAL INSTITUTE (AMT) - IDIQ FOR BIOLOGICAL NONCLINICAL SERVICES
Other Administrative Action
$0
9/7/22
P00002
BATTELLE MEMORIAL INSTITUTE (AMT) - IDIQ FOR BIOLOGICAL NONCLINICAL SERVICES
Other Administrative Action
$0
2/17/22
P00001
BATTELLE MEMORIAL INSTITUTE (AMT) - IDIQ FOR BIOLOGICAL NONCLINICAL SERVICES
Other Administrative Action
$0
3/30/20
Not listed
BATTELLE MEMORIAL INSTITUTE (AMT) - IDIQ FOR BIOLOGICAL NONCLINICAL SERVICES
Not listed
$50.0k
3/3/17
Name
Description
Awardee
Potential Value
(Click to sort descending)
Award Date
(Click to sort descending)
Completion Date
(Click to sort descending)
Updated At
(Click to sort descending)
Delivery Order HHSO100201700011I-HHSO10033003T
Battelle Memorial Institute, doing business as Battelle, has been awarded a $1,750,781 delivery order against the Biological Animal Model Development 2017-2022 master IDIQ contract held with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The delivery order has no set-aside designation and work is to be performed in Columbus, Ohio through August 2019. The master IDIQ was awarded by HHS ASPR to develop biological animal models in support of the agency's programs. Under this delivery order, Battelle will provide research services utilizing such models to advance the Biological Advanced Research and Development Authority's initiatives for medical countermeasure and vaccine development. As the largest nonprofit research organization, Battelle frequently receives prime contracts and subawards to conduct scientific and technical work for various federal agencies.
Battelle Memorial Institute
$0
8/25/17
8/28/19
3/5/24
Delivery Order HHSO100201700011I-75A50121F33014
This federal contract award, valued at up to $7,430,997.33, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) under the BARDA Biological Animal Model Development 2017-2022 contract vehicle. The prime contractor is Battelle Memorial Institute, a nonprofit research and development organization, to conduct studies in non-human primate models of filovirus infection for the purpose of assay optimization and qualification. The contract has no set-aside designation. Major subcontractors include Boston University Medical Campus, the University of Texas Medical Branch at Galveston, and the Texas Biomedical Research Institute, all of which have extensive experience in biomedical research, animal model development, and supporting federal agencies' public health and medical countermeasure initiatives.
Battelle Memorial Institute
$7.4m
9/3/21
12/31/25
11/14/24
Delivery Order HHSO100201700011I-75A50121F33015
This is a delivery order awarded by the Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Battelle Memorial Institute (Battelle) for biological nonclinical services. The award, valued at $1,377,046.00, is issued under Battelle's BARDA Biological Animal Model Development 2017-2022 indefinite-delivery, indefinite-quantity (IDIQ) contract. The work will be performed in Columbus, Ohio, and there is no set-aside designation. Battelle is a non-profit organization and manufacturer of goods that frequently provides research, engineering, testing, manufacturing, and information technology services to U.S. federal government agencies through prime and subcontract awards, including the National Institutes of Health, Department of Energy, and Environmental Protection Agency.
Battelle Memorial Institute
$1.4m
9/17/21
2/28/23
1/27/23
Delivery Order HHSO100201700011I-75A50120F33012
This is a delivery order issued against the BARDA Biological Animal Model Development 2017-2022 IDIQ contract, awarded by the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR) to Battelle Memorial Institute. The $9,646,173 contract is for the development of animal models to evaluate medical countermeasures for SARS-CoV-2. Battelle, a nonprofit research and development organization, has extensive experience supporting federal agencies through prime and subcontract awards across domains like defense, health, and homeland security. Several subcontractors are supporting this effort, including Meso Scale Diagnostics for SARS-CoV-2 antibody detection kits, Integral Molecular for reagents, and firms providing ferrets for infectious disease research.
Battelle Memorial Institute
$9.6m
3/30/20
2/28/25
10/7/24
Delivery Order HHSO100201700011I-75A50119F33009
This is a delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the Department of Health and Human Services (HHS) to Battelle Memorial Institute for $6,950,153.00 to provide biological nonclinical services. The order is issued against Battelle's $100 million IDIQ contract for biological animal model and medical countermeasure development through BARDA, which supports federal efforts to enhance pandemic preparedness and response capabilities. The work involves conducting studies using non-human primate models to investigate filovirus infections, with subcontractors Texas Biomedical Research Institute, Envigo Global Services Inc., and the University of Texas Medical Branch at Galveston providing specialized research services and animal models. This delivery order does not have a set-aside designation.
Battelle Memorial Institute
$7.0m
9/20/19
3/31/25
10/9/24
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
BARDA Biological Animal Model Development
Within the Federal government, the Department of Health and Human Services (HHS) is tasked with protecting the civilian population by providing leadership in research, development, acquisition, deployment, and use of effective medical countermeasures for the adverse health effects resulting from intentional exposure to CBRN threat agents, pandemics and emerging infectious disease threats. HHS, through the interagency Public Health Emergency and Medical Countermeasure Enterprise (PHEMCE) is responsible for the integration of requirements for the advanced development and procurement of medical countermeasures for CBRN, pandemic influenza and emerging infectious disease threats. The 2014 HHS PHEMCE Strategy and Implementation Plan describes the strategic policy goals and objectives for identifying requirements and establishes the priorities for the development of the medical countermeasures against chemical, biological, radiological, and nuclear threats, pandemic influenza and emerging infectious diseases. The Nonclinical Studies Network is a key element in the successful development of medical countermeasures for biological threats, particularly since efficacy of products directed against most of these threats cannot be verified using clinical studies. The United States Government (USG) therefore seeks appropriate Good Laboratory Practices (GLP) facilities that are adequate and available to support establishing new or existing animal tests and/or models for the development of Biological Medical Countermeasures (MCMs) against biological threats, influenza and emerging infectious diseases. The United States Government (USG) seeks to maintain a network of GLP laboratories that will provide capability for nonclinical animal studies, analytical services, and toxicology services in support of the BARDA portfolio. In these models, the challenge dose generally should be the same as that which produces the human disease or condition and the pathophysiological mechanism of its toxicity should be reasonably well-understood and mimic the human disease/condition as closely as possible. When these models are used to test the efficacy of potential MCMs for CRN agents, the mechanism of action of the countermeasure will need to establish the utility of the animal model as a surrogate for humans. BARDA anticipates that contracts awarded from this RFP will serve to facilitate the animal model development of medical countermeasures and/or supportive reagents and assays for regulatory acceptance in the U.S. HHS, through AMCG and BARDA, anticipates 9-12 contract awards will be made to establish capabilities in toxicology, analytical services and nonclinical (animal) testing through Indefinite Delivery Indefinite Quantity (IDIQ) contracts. The anticipated period of performance for any resultant contracts will be for a total of up to 60 months. Additional details and requirements will be described in the solicitation. Offeror's will be required to respond to Sample Request for Task Order Response (RTOR) documents as part of their proposal. Mandatory Criteria for Eligibility Offerors must meet the following mandatory criterion for eligibility for an Analytical Services award:1. GLP Capabilities: To demonstrate compliance with the mandatory requirement to have existing GLP capabilities, the Offeror must have at least one completed GLP study. Provide a list of all GLP studies conducted in the past three years. (Confidential information can be redacted.) Offerors must meet the following mandatory criterion for eligibility for an Animal Model Testing award: 1. GLP Capabilities: To demonstrate compliance with the mandatory requirement to have existing GLP capabilities, the Offeror must have at least one completed GLP study. Provide a list of all GLP studies conducted in the past three years. (Confidential information can be redacted.)2. The Offeror shall be a part of the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) accreditation or equivalent. The Offeror shall provide evidence of these required licenses. 3. The Offeror shall have a U.S. Department of Agriculture (USDA) animal research facility license, or equivalent. The Offeror shall provide evidence of having a USDA licensed facility or equivalent (OLAW Assurance). 4. The Offeror shall have Federal, State, and/or local licenses as required for the storage, use, and disposal of select agents and training of all associated staff responsible for the use of such material. The Offeror shall provide documentation of CDC/USDA Select Agent registration. Offerors must meet the following mandatory criterion for eligibility for a Toxicology Services award:1. GLP Capabilities: To demonstrate compliance with the mandatory requirement to have existing GLP capabilities, the Offeror must have at least one completed GLP study. Provide a list of all GLP studies conducted in the past three years. (Confidential information can be redacted.)2. The Offeror shall be a part of the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) accreditation or equivalent. The Offeror shall provide evidence of these required licenses. 3. The Offeror shall have a U.S. Department of Agriculture (USDA) animal research facility license, or equivalent. The Offeror shall provide evidence of having a USDA licensed facility or equivalent.(OLAW Assurance). Pre-solicitation Notice ObjectiveThis Pre-solicitation Notice is issued pursuant to FAR Subpart 5.2. It does not constitute a Request for Proposal (RFP) or a promise to issue an RFP in the future. This Pre-solicitation Notice does not commit the Government to contract for any supply or service whatsoever. Further, AMCG is not at this time seeking proposals, and will not accept unsolicited proposals. It is anticipated that an RFP will be available electronically through the FedBizOpps website on or about February 15, 2016, with proposals being due on or about March 29, 2016. Any responsible offeror may submit a proposal that will be considered by the Government. It is the offeror's responsibility to monitor this internet site (www.fbo.gov) for the release of this solicitation as well as any amendments. Potential offerors will be responsible for downloading their own copy of the solicitation and any amendments via this website. No collect calls will be accepted. No facsimile transmissions will be accepted. All responses should be identified with the RFP number, name of firm, size standard of the firm, name of requestor, mailing address, telephone number, fax number, and email address, and should be submitted to the Point of Contact(s) identified in this notice. Multiple awards may result from this solicitation with an estimated award date in June 2016. Furthermore, all respondents must be registered in the System for Award Management (SAM) https://www.sam.gov and have their records updated in the Central Contractor Registry (CCR).
RFP-16-100-SOL-00008
Department of Health and Human Services Immediate Office of the Secretary
Pre-Solicitation 1/2
1/8/16, 2:47 PM
BARDA Biological Animal Model Development
Awarded contract HHSO100201700018I to Southern Research Institute for $50,000 (IDIQ Minimum Guarantee) on 2017-03-06.
RFP-16-100-SOL-00008
Department of Health and Human Services Immediate Office of the Secretary
Award Notice 2/2
3/7/17, 10:18 AM